Charles Schwab’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$37.2M Buy
356,651
+19,405
+6% +$2.03M 0.01% 1279
2025
Q1
$39.3M Buy
337,246
+9,212
+3% +$1.07M 0.01% 1231
2024
Q4
$27.8M Buy
328,034
+5,438
+2% +$460K 0.01% 1509
2024
Q3
$29M Buy
322,596
+12,778
+4% +$1.15M 0.01% 1480
2024
Q2
$24.9M Buy
309,818
+8,744
+3% +$704K ﹤0.01% 1527
2024
Q1
$24M Buy
301,074
+5,373
+2% +$429K 0.01% 1504
2023
Q4
$23.5M Buy
295,701
+5,830
+2% +$464K 0.01% 1486
2023
Q3
$20.3M Buy
289,871
+21,457
+8% +$1.5M 0.01% 1504
2023
Q2
$19.3M Buy
268,414
+19,296
+8% +$1.39M 0.01% 1530
2023
Q1
$15.4M Sell
249,118
-652
-0.3% -$40.2K ﹤0.01% 1650
2022
Q4
$19.3M Buy
249,770
+23,417
+10% +$1.81M 0.01% 1473
2022
Q3
$10.1M Buy
226,353
+12,067
+6% +$538K ﹤0.01% 1821
2022
Q2
$8.21M Buy
214,286
+1,073
+0.5% +$41.1K ﹤0.01% 1938
2022
Q1
$8.83M Buy
213,213
+5,983
+3% +$248K ﹤0.01% 2020
2021
Q4
$7.83M Buy
207,230
+3,178
+2% +$120K ﹤0.01% 2130
2021
Q3
$6.73M Buy
204,052
+17,957
+10% +$592K ﹤0.01% 2232
2021
Q2
$12.6M Buy
186,095
+3,253
+2% +$219K ﹤0.01% 1882
2021
Q1
$10.4M Buy
182,842
+5,575
+3% +$316K ﹤0.01% 1946
2020
Q4
$14.4M Buy
177,267
+1,854
+1% +$151K 0.01% 1629
2020
Q3
$12.5M Sell
175,413
-5,627
-3% -$401K 0.01% 1533
2020
Q2
$14.9M Buy
181,040
+13,210
+8% +$1.09M 0.01% 1380
2020
Q1
$9.87M Buy
167,830
+7,652
+5% +$450K 0.01% 1454
2019
Q4
$16.6M Buy
160,178
+7,667
+5% +$792K 0.01% 1349
2019
Q3
$3.09M Buy
152,511
+95,814
+169% +$1.94M ﹤0.01% 2215
2019
Q2
$1.46M Buy
+56,697
New +$1.46M ﹤0.01% 2464
2017
Q2
Sell
-17,700
Closed -$70K 3105
2017
Q1
$70K Hold
17,700
﹤0.01% 3032
2016
Q4
$120K Hold
17,700
﹤0.01% 3029
2016
Q3
$140K Hold
17,700
﹤0.01% 2981
2016
Q2
$134K Buy
+17,700
New +$134K ﹤0.01% 3026